J IRAN CHEM SOC (2013) 10:55–62
59
1,3-Di-n-propyl-5-(20-bromobenzyloxy-50-methoxy)-pyrimi-
dine-2,4-dione (6h, C18H23BrN2O4). Yield: 86 %; m.p.:
Typical procedure for synthesis of 1H,3H,6H[2]
benzopyrano[4,3-d]pyrimidine-2,4-diones 7(a–k)
62–64 °C; IR (neat) t
‹ = 2,937, 2,877, 1,704, 1,661,
1,456 cm-1; 1H NMR (400 MHz, CDCl3) d = 0.90 (t, 3H,
J = 7.2 Hz, C–CH3), 0.97 (t, 3H, J = 7.2 Hz, C–CH3),
1.62–1.70 (m, 4H, CH2CH2CH3), 3.65 (t, 2H, J = 7.6 Hz,
–N–CH2), 3.79 (s, 3H, O–CH3), 3.96 (t, 2H, J = 7.6 Hz,
–N–CH2), 5.07 (s, 2H, O–CH2), 6.74–6.76 (d, 1H,
J = 8.8 Hz, ArH), 6.81 (s, 1H, =CH), 7.10 (s, 1H, ArH),
7.42–7.45 (d, 1H, J = 8.8 Hz, ArH); 13C NMR (100 MHz,
CDCl3) d = 10.9, 11.4, 20.9, 22.2, 43.4, 51.3, 55.7, 72.9,
113.4, 115.5, 116.0, 129.0, 133.3, 133.4, 133.6, 150.2, 159.3,
160.1; MS (EI): m/z = 410; analysis: C18H23BrN2O4,
calcd.: C, 52.56; H, 5.64; N, 6.81 %; found: C, 52.42; H,
5.72; N, 6.94 %.
A mixture of n-Bu3SnH (0.75 mmol, 1.5 equiv) and AIBN
(22 mg, 0.13 mmol, 0.25 equiv) in toluene (10 ml) was
added via a syringe pump over 1 h to a MWI at
100–110 °C under open-vessel conditions in the solution of
6 (0.5 mmol, 1.0 equiv) and AIBN (22 mg, 0.13 mmol,
0.25 equiv) in toluene (10 ml). The reaction was monitored
by TLC, and after completion of the reaction, solvent was
evaporated by rotavapour and it was extracted with CH2Cl2
(2 9 20 ml), washed with 1 % aqueous NH4OH (2 9
10 ml) and brine. Evaporation of the solvent furnished the
residual mass which was then magnetically stirred with
saturated solution of potassium fluoride. It was again
extracted with CH2Cl2 (3 9 10 ml) and was washed sev-
eral times with water and dried (Na2SO4). The residual
mass after removal of the solvent (CH2Cl2) was subjected
to flash column chromatography using petroleum ether:-
ethyl acetate (1:2) as eluant to give cyclised products 7.
Cyclised products 7(a–f) are known and were easily
identified by comparison of their spectroscopic data and
m.p.’s with those reported [65]. New products 7(g–k) were
characterised by elemental analyses, mass spectrometry,
1,3-Di-n-butyl-5-(20-bromobenzyloxy)pyrimidine-2,4-dione
(6i, C19H25BrN2O3). 1Yield: 84 %; m.p.: 87–88 °C;
1
IR (neat) t
‹
= 2,922, 2,861, 1,712, 1,690, 1,442 cm-1; H
NMR (400 MHz, CDCl3) d = 0.88 (t, 6H, J = 7.5 Hz, C–
CH3), 1.28 (sextet, 4H, J = 7.5 Hz, –NCH2CH2CH2CH3),
1.76 (quintet, 4H, J = 7.5 Hz, –NCH2CH2CH2CH3), 3.66
(t, 4H, J = 7.5 Hz, –N–CH2–), 5.18 (s, 2H, O–CH2), 6.88
(s, 1H, =CH), 7.31–7.39 (m, 1H, ArH), 7.41–7.55 (m, 2H,
ArH), 7.61–7.89 (m, 1H, ArH); MS (EI): m/z = 410;
analysis: C19H25BrN2O3, calcd.: C, 55.75; H, 6.16; N,
6.84 %; found: C, 55.61; H, 6.06; N, 6.99 %.
1
infrared and mono H, 13C{1H}-NMR spectroscopy.
1,3-Di-n-propyl-6H-[2]benzopyrano[4,3-d]pyrimidine-2,4-
dione (7g, C17H20N2O3). Yield: 88 %; white solid; m.p.:
1,3-Di-n-butyl-5-(20-bromobenzyloxy-50-methoxy)-pyrimi-
dine-2,4-dione (6j, C20H27BrN2O4). Yield: 87 %; m.p.:
101–102 °C; IR (neat) t
‹ = 2,940, 1,715, 1,649, 1,492
cm-1 1H NMR (400 MHz, CDCl3) d = 0.97 (t, 3H,
;
90–92 °C; IR (neat) t
‹ = 2,917, 2,861, 1,709, 1,650,
J = 7.2 Hz, C–CH3), 0.98 (t, 3H, J = 7.2 Hz, C–CH3),
1.64–1.82 (m, 4H, CH2CH2CH3), 3.85 (t, 2H, J = 7.6 Hz,
–N–CH2), 3.97 (t, 2H, J = 7.6 Hz, –N–CH2), 4.46 (s, 2H,
O–CH2), 7.25–7.38 (m, 1H, ArH), 7.42–7.66 (m, 2H, ArH),
7.68–7.88 (m, 1H, ArH); 13C NMR (100 MHz, CDCl3)
d = 11.0, 11.6, 19.3, 21.2, 48.7, 51.0, 65.4, 115.6, 117.9,
123.7, 126.5, 127.8, 129.2, 134.4, 137.7, 152.8, 164.6; MS
(EI): m/z = 300; analysis: C17H20N2O3, calcd.: C, 67.98;
H, 6.71; N, 9.33 %; found: C, 67.82; H, 6.88; N, 9.24 %.
1,440 cm-1; 1H NMR (400 MHz, CDCl3) d = 0.88 (t, 6H,
J = 7.5 Hz, C–CH3), 1.32 (sextet, 4H, J = 7.5 Hz,
–NCH2CH2CH2CH3), 1.71 (quintet, 4H, J = 7.5 Hz,
–NCH2CH2CH2CH3), 3.52 (t, 4H, J = 7.5 Hz, –N–CH2–),
3.88 (s, 3H, O–CH3), 5.15 (s, 2H, O–CH2), 6.92–6.99 (d, 1H,
J = 8.0 Hz, ArH), 6.98 (s, 1H, =CH), 7.11–7.21 (m, 1H,
ArH), 7.31–7.59 (d, 1H, J = 8.0 Hz, ArH); MS (EI):
m/z = 438; analysis: C20H27BrN2O4, calcd.: C, 54.68; H,
6.19; N, 6.38 %; found: C, 54.54; H, 6.36; N, 6.44 %.
1,3-Di-n-propyl-6H-[2]benzopyrano[4,3-d]8-methoxy pyr-
Yield: 82 %;
1,3-Bis-(2-methoxyethyl)-5-(20-bromobenzyloxy) pyrimi-
imidine-2,4-dione (7h, C18H22N2O4).
white solid; m.p.: 97–98 °C; IR (neat) t
‹
= 2,928, 1,710,
dine-2,4-dione (6k, C17H21BrN2O5). Yield: 78 %; m.p.:
1,651, 1,498 cm-1; 1H NMR (400 MHz, CDCl3) d = 0.94
(t, 3H, J = 7.2 Hz, C–CH3), 0.99 (t, 3H, J = 7.2 Hz, C–
CH3), 1.64–1.81 (m, 4H, CH2CH2CH3), 3.76 (t, 2H,
J = 7.6 Hz, –N–CH2), 3.89 (s, 3H, O–CH3), 3.98 (t, 2H,
J = 7.6 Hz, –N–CH2), 4.41 (s, 2H, O–CH2), 7.12–7.29 (m,
1H, ArH), 7.34–7.49 (m, 1H, ArH), 7.58 (s, 1H, ArH); MS
(EI): m/z = 330; analysis: C18H22N2O4, calcd.: C, 65.44;
H, 6.71; N, 8.48 %; found: C, 65.51; H, 6.58; N, 8.62 %.
98–99 °C; IR (neat) t
‹ = 2,908, 2,865, 1,722, 1,699,
1,468 cm-1; 1H NMR (400 MHz, CDCl3) d = 3.27 (s, 6H,
OCH3), 3.69 (t, 4H, J = 6.8 Hz, –CH2–), 4.14 (t, 4H,
J = 6.8 Hz, –N–CH2–), 5.23 (s, 2H, O–CH2), 6.97 (s, 1H,
=CH), 7.19–7.48 (m, 1H, ArH), 7.51–7.65 (m, 1H, ArH),
7.68–7.99 (m, 2H, ArH); MS (EI): m/z = 412; analysis:
C17H21BrN2O5, calcd.: C, 49.41; H, 5.12; N, 6.78 %;
found: C, 49.52; H, 5.30; N, 6.89 %.
123